Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Cash from Investing Activities: 2021-2025

Historic Cash from Investing Activities for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$1.8 billion.

  • Roivant Sciences' Cash from Investing Activities rose 103.66% to $120.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 billion, marking a year-over-year decrease of 480.52%. This contributed to the annual value of -$1.8 billion for FY2025, which is 133.94% down from last year.
  • As of FY2025, Roivant Sciences' Cash from Investing Activities stood at -$1.8 billion, which was down 133.94% from $5.2 billion recorded in FY2024.
  • Roivant Sciences' 5-year Cash from Investing Activities high stood at $5.2 billion for FY2024, and its period low was -$1.8 billion during FY2025.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$44.3 million (2023), whereas its average is $1.1 billion.
  • As far as peak fluctuations go, Roivant Sciences' Cash from Investing Activities surged by 11,854.55% in 2024, and later slumped by 133.94% in 2025.
  • Yearly analysis of 5 years shows Roivant Sciences' Cash from Investing Activities stood at -$31.7 million in 2021, then spiked by 1,056.71% to $303.3 million in 2022, then tumbled by 114.60% to -$44.3 million in 2023, then soared by 11,854.55% to $5.2 billion in 2024, then crashed by 133.94% to -$1.8 billion in 2025.